Manager × security

Westside Investment Management, Inc. ETON holdings history

Who else holds this security? →

ETON PHARMACEUTICALS INC · CUSIP 29772L108 · CIK 1538383

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Westside Investment Management, Inc. reported 431.16K ETON (shares), valued at $15.61M, or 2.05% of its reported non-derivative portfolio. Filed 2026-07-27.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
2.05%
Shares
431.16K
431,160
Reported value
$15.61M
USD

Shares decreased 7.86%; reported value increased 35.15%, and weight changed +0.28 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20262.05%431,160SEC filing ↗Filed Jul 27, 2026
Q1 20261.77%467,915SEC filing ↗Filed May 4, 2026
Q4 20251.27%470,940SEC filing ↗Filed Jan 23, 2026
Q3 20251.64%472,540SEC filing ↗Filed Nov 4, 2025
Q2 20251.25%472,790SEC filing ↗Filed Aug 5, 2025
Q1 20251.36%493,650SEC filing ↗Filed Apr 25, 2025
Q4 20241.61%575,222SEC filing ↗Filed Jan 17, 2025
Q3 20240.79%618,675SEC filing ↗Filed Nov 20, 2024
Q2 20240.44%585,400SEC filing ↗Filed Jul 17, 2024
Q1 20240.52%573,960SEC filing ↗Filed Apr 19, 2024
Q4 20230.63%563,110SEC filing ↗Filed Jan 12, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20230.63%563,110$2.47MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Jan 12, 2024
Q1 20240.52%573,960$2.15MShares increased 1.93%; reported value decreased 12.73%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 19, 2024
Q2 20240.44%585,400$1.93MShares increased 1.99%; reported value decreased 10.52%, and weight changed -0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 17, 2024
Q3 20240.79%618,675$3.71MShares increased 5.68%; reported value increased 92.67%, and weight changed +0.35 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 20, 2024
Q4 20241.61%575,222$7.66MShares decreased 7.02%; reported value increased 106.47%, and weight changed +0.82 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 17, 2025
Q1 20251.36%493,650$6.41MShares decreased 14.18%; reported value decreased 16.37%, and weight changed -0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 25, 2025
Q2 20251.25%472,790$6.74MShares decreased 4.23%; reported value increased 5.15%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 5, 2025
Q3 20251.64%472,540$10.27MShares decreased 0.05%; reported value increased 52.40%, and weight changed +0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 4, 2025
Q4 20251.27%470,940$7.96MShares decreased 0.34%; reported value decreased 22.44%, and weight changed -0.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 23, 2026
Q1 20261.77%467,915$11.55MShares decreased 0.64%; reported value increased 45.02%, and weight changed +0.50 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 4, 2026
Q2 20262.05%431,160$15.61MShares decreased 7.86%; reported value increased 35.15%, and weight changed +0.28 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 27, 2026
Westside Investment Management, Inc. · ETON PHARMACEUTICALS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1538383","quarter":"2026Q2","cusip":"29772L108"}

get_institutional_manager_history
{"cik":"1538383","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.